Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00151463
Status:
COMPLETED
Last Update Posted:
2021-02-01
First Post:
2005-09-07
Brief Title:
QEQ Treatment Responsiveness Evaluation Study
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
An Open-Label Non-Comparative Study To Evaluate Treatment Responsiveness To The Quality Of Erection Questionnaire QEQ In Men With Erectile Dysfunction Treated With Viagra Sildenafil Citrate
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Quality of Erection Questionnaire QEQ is a new questionnaire that was developed to assess erectile attributes in men with erectile dysfunction The study objective is to validate the Quality of Erection Questionnaire QEQ through the evaluation of subject responses to the QEQ regarding the quality and hardness of erections at baseline compared to subject responses post 6 and 10 weeks dosing with Viagra sildenafil citrate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None